Purchases and Sales Made in Q3 2022 in Processa Pharmaceuticals, Inc. (PCSA)
This table provides information about the institutional ownership of Processa Pharmaceuticals, Inc. (PCSA) during Q3 2022. The information is specifically focused on institutions that hold shares of Processa Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
12.5KNew |
$24.9K - $583K
|
12.5K
$11.5K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.14K+ 219.52% |
$6.27K - $147K
|
4.57K
$4.2K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
100+ 0.03% |
$200 - $4.68K
|
374K
$344K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
100+ 0.86% |
$200 - $4.68K
|
11.7K
$10.8K
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
15+ 1.5% |
$30 - $702
|
1.02K
$934
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
6+ 0.19% |
$12 - $281
|
3.15K
$2.9K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-785- 2.74% |
$1.57K - $36.7K
|
27.8K
$25.6K
|